Synthetic Antibodies
Synthetic Antibodies

Author: Thomas Tiller

Publisher: Humana

Published: 2018-06-20

Total Pages: 420

ISBN-13: 9781493983193

DOWNLOAD EBOOK

This detailed volume presents a set of protocols useful for researchers in the field of recombinant immunoglobulin and alternative scaffold engineering, aptamer development, and generation of molecularly imprinted polymers (MIPs). Part I includes methods that deal with amino-acid based synthetic antibodies. Brief protocols about the generation of antibody libraries are detailed, as well as techniques for antibody selection, characterization, and validation. This section is completed by a brief description of a bioinformatics platform that supports antibody engineering during research and development. Part II contains basic procedures about the selection and characterization of aptamer molecules, and Part III describes fundamental processes of MIP generation and application. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and practical, Synthetic Antibodies: Methods and Protocols is an ideal guide for scientists seeking to propel the vital study of antibody research.

Structural Biology in Immunology
Structural Biology in Immunology

Author: Chaim Putterman

Publisher: Academic Press

Published: 2018-05-14

Total Pages: 192

ISBN-13: 0128033703

DOWNLOAD EBOOK

Structural Biology in Immunology, Structure/Function of Novel Molecules of Immunologic Importance delivers important information on the structure and functional relationships in novel molecules of immunologic interest. Due to an increasingly sophisticated understanding of the immune system, the approach to the treatment of many immune-mediated diseases, including multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, and inflammatory bowel disease has been dramatically altered. Furthermore, there is an increasing awareness of the critical role of the immune system in cancer biology. The improved central structure function relationships presented in this book will further enhance our ability to understand what defects in normal individuals can lead to disease. Describes novel/recently discovered immunomodulatory proteins, including antibodies and co-stimulatory or co-inhibitory molecules Emphasizes new biologic and small molecule drug design through the exploration of structure-function relationship Features a collaborative editorial effort, involving clinical immunologists and structural biologists Provides useful and practical insights on developing the necessary links between basic science and clinical therapy in immunology Gives interested parties a bridge to learn about computer modeling and structure based design principles

Coupling Synthetic Antibodies with Mass Cytometry Allows the Development of a Highly Tailored, Multi-Parametric Single Cell Analysis Strategy
Coupling Synthetic Antibodies with Mass Cytometry Allows the Development of a Highly Tailored, Multi-Parametric Single Cell Analysis Strategy

Author: Amy Hu

Publisher:

Published: 2017

Total Pages: 0

ISBN-13:

DOWNLOAD EBOOK

Increased appreciation for the inherent heterogeneity in cell populations has prompted a demand for more parameters at the single cell level. Synthetic antibody technology allows the rapid development of monoclonal antibodies with exquisite specificity towards any cellular epitope of interest, surpassing traditional hybridoma techniques. A new technology termed mass cytometry (CyTOF) improves on conventional fluorescence detection by labeling antibodies with metal isotope tags, significantly increasing the parameters that can be distinguished simultaneously. In this thesis, the convergence of synthetic antibody technology with mass cytometry is proposed. A comprehensive set of synthetic antibodies towards the Eph Receptor family is amended and tested for use in CyTOF. After validation, this toolset is applied to the study of cancer heterogeneity in Glioblastoma Multiforme. Subsequent analysis by ViSNE and SPADE unearths a putative brain tumour initiating cell population, illustrating an example of the potential afforded through combining these technologies.

Antibodies
Antibodies

Author: A. Szentivanyi

Publisher: Springer Science & Business Media

Published: 2013-03-07

Total Pages: 208

ISBN-13: 1461318734

DOWNLOAD EBOOK

This publication is based on a Symposium that has been held in Clearwater, Florida on February 19-21, 1986, on antibodies, their structure, synthesis, function, and clinical applicability in disease. Organization of this symposium by the University of South Florida College of Medicine was prompted by the unparalleled current expansion of information on these topics in general, and in the field of antibody diver sity, in particular. The issues that surround the last named dimension of this field, began to surface in the late 1950's with the first conclusive genetic studies having been answered, and a new set of concepts has been de fined. As we see it from the material presented in this volume, now new and different questions are being raised and answered by studies in progress, and it may be expected that there will be other questions that will be with us for a considerably longer time. We believe that the symposium brought together many prominent investi gators with different backgrounds and training experiences such as immunolo gists, microbiologists, biochemists, molecular biologists, and clinical sci entists, thus providing an excellent example of the interdisciplinary value of modern immunology and modern biomedical science in general. We believe, therefore, that bringing these complex topics to a wide audience of bio medical scientists through this symposium as well as this volume is of value to the scientific and to the medical community.

Monoclonal Antibody Production
Monoclonal Antibody Production

Author: National Research Council

Publisher: National Academies Press

Published: 1999-05-06

Total Pages: 74

ISBN-13: 0309173051

DOWNLOAD EBOOK

The American Anti-Vivisection Society (AAVS) petitioned the National Institutes of Health (NIH) on April 23, 1997, to prohibit the use of animals in the production of mAb. On September 18, 1997, NIH declined to prohibit the use of mice in mAb production, stating that "the ascites method of mAb production is scientifically appropriate for some research projects and cannot be replaced." On March 26, 1998, AAVS submitted a second petition, stating that "NIH failed to provide valid scientific reasons for not supporting a proposed ban." The office of the NIH director asked the National Research Council to conduct a study of methods of producing mAb. In response to that request, the Research Council appointed the Committee on Methods of Producing Monoclonal Antibodies, to act on behalf of the Institute for Laboratory Animal Research of the Commission on Life Sciences, to conduct the study. The 11 expert members of the committee had extensive experience in biomedical research, laboratory animal medicine, animal welfare, pain research, and patient advocacy (Appendix B). The committee was asked to determine whether there was a scientific necessity for the mouse ascites method; if so, whether the method caused pain or distress; and, if so, what could be done to minimize the pain or distress. The committee was also asked to comment on available in vitro methods; to suggest what acceptable scientific rationale, if any, there was for using the mouse ascites method; and to identify regulatory requirements for the continued use of the mouse ascites method. The committee held an open data-gathering meeting during which its members summarized data bearing on those questions. A 1-day workshop (Appendix A) was attended by 34 participants, 14 of whom made formal presentations. A second meeting was held to finalize the report. The present report was written on the basis of information in the literature and information presented at the meeting and the workshop.

Recombinant Antibodies for Infectious Diseases
Recombinant Antibodies for Infectious Diseases

Author: Theam Soon Lim

Publisher: Springer

Published: 2018-12-12

Total Pages: 0

ISBN-13: 9783030101534

DOWNLOAD EBOOK

There are many principles and applications of recombinant antibodies for infectious diseases. The preferred technology associated to recombinant antibody generation is mainly phage display. The adaptation of antibodies for infectious diseases is an area lacking information as most literature is focused on oncology or autoimmunity. This project highlights the power and potential of antibody phage display for infectious diseases. In addition to that, supplementary information regarding technologies associated to antibody generation and engineering in the context of infectious disease will also help to provide greater insight to the potential of recombinant antibodies for infectious diseases.